Français
ItalianoBond AbbVie 4.85% ( USU0029QBF29 ) in USD
| Issuer | AbbVie | ||||||||||||||||||||||||||||||
| Market price |  100.00 % ▼ |
||||||||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||||||||
| ISIN code |
 USU0029QBF29 ( in USD )
|
||||||||||||||||||||||||||||||
| Interest rate | 4.85% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||
| Maturity | 15/06/2044 | ||||||||||||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||||||
| Total amount | 1 008 583 000 USD | ||||||||||||||||||||||||||||||
| Cusip | U0029QBF2 | ||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||
| Moody's rating | N/A | ||||||||||||||||||||||||||||||
| Next Coupon | 15/12/2026 ( In 111 days ) | ||||||||||||||||||||||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code USU0029QBF29, pays a coupon of 4.85% per year. The coupons are paid 2 times per year and the Bond maturity is 15/06/2044 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code USU0029QBF29, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||